Check Abcellera Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
-0.6025
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.46%
PE Ratio (TTM)
-4.86
Industry PE ratio
-3.9415151515151514
P/B Ratio
0PEG Ratio
0EBITDA
-218.4M
Revenue (TTM)
32.9M
Profit Margin
0.00%
Return On Equity TTM
8199400.00%
Track how Abcellera Biologics Inc P/E has moved over time to understand its valuation trends.
Abcellera Biologics Inc in the last 5 years
Lowest (13.44x)
June 30, 2022
Today (-4.86x)
September 18, 2025
Industry (-3.94x)
September 18, 2025
Highest (115.25x)
December 31, 2020
Today’s Price to Earnings Ratio: -4.86x
Compare market cap, revenue, PE, and other key metrics of Abcellera Biologics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.4B | NA | -4.86 | 0.00% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Abcellera Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Abcellera Biologics Inc investment value today
Current value as on today
₹1,76,226
Returns
₹76,226
(+76.23%)
Returns from Abcellera Biologics Inc Stock
₹71,273 (+71.27%)
Dollar Returns*
₹4,953 (+4.95%)
Based on 15 analysts
93.33%
Buy
6.67%
Hold
0.00%
Sell
Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Abcellera Biologics Inc. Average target price of $9.33
Get share price movements and forecasts by analysts on Abcellera Biologics Inc.
What analysts predicted
49.52%UPSIDE
Target Price
$9.33
Current Price
$4.71
Analyzed by
15 Analysts
Target
$9.33
Abcellera Biologics Inc target price $9.33, a slight upside of 49.52% compared to current price of $4.71. According to 15 analysts rating.
Investment in Abcellera Biologics Inc Shares on INDmoney has dropped by -32.79% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Abcellera Biologics Inc Stock has decreased by -64% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, -45.62M → -34.72M (in $), with an average increase of 31.4% per quarter
Price Rise
In the last 6 months, ABCL stock has moved up by 91.2%
Revenue Rich
Revenue is up for the last 2 quarters, 4.23M → 17.08M (in $), with an average increase of 75.2% per quarter
Against Peers
In the last 3 years, Beone Medicines Ltd has given 114.6% return, outperforming this stock by 170.7%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 67.3% return, outperforming this stock by 0.5%
Organisation | Abcellera Biologics Inc |
Headquarters | 150 West 4th Ave, Vancouver, BC, Canada, V5Y 1G6 |
Industry | Healthcare |
CEO | Dr. Carl L.G. Hansen Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Tiffany Chiu B.Sc., Ph.D. | Vice President of Communications |
Caitlin Webster CIPD, M.Sc. | Director of Talent Development |
Dr. Carl L.G. Hansen Ph.D. | CEO, President & Chairperson |
Mr. Andrew Booth M.B.A. | Chief Financial Officer |
Mr. Andrew Knowles M.Sc. | VP of Operations |
Graham Craig M.Sc. | Director of Corporate Development |
Mr. Murray McCutcheon Ph.D. | Senior Vice President of Partnering |
Dr. Veronique Lecault Ph.D. | CTO & Director |
Mr. Tryn T. Stimart Esq., J.D., M.Sc. | Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer |
Marcie Thiessen CPA, CGA | Senior Director of Finance & Accounting |
Abcellera Biologics Inc share price today is $4.71 as on at the close of the market. Abcellera Biologics Inc share today touched a day high of $4.79 and a low of $4.6.
Abcellera Biologics Inc share touched a 52 week high of $5.82 on and a 52 week low of $1.89 on . Abcellera Biologics Inc stock price today i.e. is closed at $4.71,which is 19.07% down from its 52 week high and 149.13% up from its 52 week low.
Abcellera Biologics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Abcellera Biologics Inc (ABCL) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Abcellera Biologics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Abcellera Biologics Inc share’s latest price of $4.71 as on September 19, 2025 at 1:29 am IST, you will get 2.1231 shares of Abcellera Biologics Inc. Learn more about
fractional shares .